3 results
To demonstrate in a phase III study that the addition of the monoclonal anti-T cell antibody alemtuzumab added to standard CHOP chemotherapy followed by autologous stam cell transplantation will increase the response, event-free survival,…
The SuMO System showed good results for mucosal resection in a porcine model. This study is developed to evaluate the feasibility and safety of the SuMO (submucosal operation) Access and Tissue Resection System in human colon and rectum tissue.
The objective of this study is to evaluate the dose-ranging response in safety and efficacy of R115866 0.5mg, 1mg and 2mg and R115866 placebo given once daily for the treatment of subjects with plaque psoriasis to select a dose for further clinical…